Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: A case-control study using quantitative coronary angiography

Heart

Volumn 78, Issue 4, 1997, Pages 337-342

  Schoebel, Frank Chris ^a   Gradaus, Frank ^a   Ivens, Katrin ^a   Heering, Peter ^a   Jax, Thomas Walter ^a   Grabensee, Bernd ^a   Strauer, Bodo Eckehard ^a   Leschke, Matthias ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Coronary angioplasty; Coronary artery disease; Renal disease; Restenosis

Indexed keywords

FIBRINOGEN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; THROMBOGENESIS; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030701968     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.4.337     Document Type: Article

References (36)

1. Lindner A, Charra B, Sherrad DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Hellerstedt WL, Johnson WJ, Ascher N, Kjellstrand CM, Knutson R, Shapiro FL, et al. Survival rates of 2728 patients with end stage renal disease. Mayo Clin Proc 1984; 59:776-83.
3. Gokal R, King J, Bogle S, Marsh F, Oliver D, Jakubowski C, et al. Outcome in patients on continous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicenter study. Lancet 1987;ii:1105-9.
4. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, et al. Report on the management of renal failure in Europe. Nephrol Dial Transplant 1992; 7(suppl2):7-35.
5. Holmes DJ, Vliestra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77-81c.
6. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-23.
7. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988;77:361-71.
8. Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994;128:252-5.
9. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-9.
10. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995;25:281-90.
11. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-41.
12. Ambrose JA, Winters SL, Arora RR, Eng A, Riccio A, Gorlin R, et al. Angiographic evaluation of coronary morphology in unstable angina. J Am Coll Cardiol 1986;7:472-8.
13. Herrington DM, Siebes M, Sokol DK, Siu CO, Walford GD. Variablity in measurements of coronary lumen dimensions using quantitative coronary angiography. J Am Coll Cardiol 1993;22:1068-74.
14. Leschke M, Blanke H, Stellwaag M, Motz W, Strauer BE. Hyperfibrinogenämie und pathologische Plasmaviskosität. Dtsch Med Wochenschr 1988;113:1175-81.
15. Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, et al. Long-term intermittent urokinase therapy in end stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial. J Am Coll Cardiol 1996;27:575-84.
16. Ceriello A, Prisi M, Giacomello R, Stel G, Falleti, Motz E, et al. Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost 1994;71:593-5.
17. Stein D, Schoebel FC, Heins M, Withold W, Pels K, Jax T, et al. Activation of the fibrinolytic system in patients with hyperfibrinogenemia and coronary artery disease and hyperfibrinogenemia. Thromb Haemost 1997;77:970-4.
18. Gris J, Branger B, Vecina F, Al Sabadani BA, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial dysfunction in dialyzed uremic patients. Kidney Int 1994;46:807-13.
19. Bauer KA, Rosenberg RD. The pathophysiology of the prothrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70:343-50.
20. Merlini PA, Bauer KA, Oltrona L, Ardissini D, Cattaneo M, Belli C, et al. Persistent activation of coagulation mechanisms in unstable angina and myocardial infarction. Circulation 1994;90:61-8.
21. Leimgruber PP, Roubin GS, Hollmann J, Catsonis GA, Meier B, Douglas IJ, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-17.
22. Quigley PJ, Hlatky MA, Hinohara S, Rendell DS, Perz JA, Philipps HR, et al. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 1989;63:409-13.
23. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost 1995;74:552-9.
24. Schoebel FC, Gradaus F, Jax TW, Stein D, Heins M, Borries M, et al. Hämostaseologische Risikofaktoren - Einfluß auf die Restenoserate nach elektiver PTCA [abstract]. Z Kardiol 1996;85(suppl 2):284.
25. Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation 1992;85:1279-85.
26. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transpl 1997;12: 1187-91.
27. Brown BG, Hillger LA, Lewis C, Zhao XQ, Sacco D, Bisson B, et al. A maximum conficence approach for measuring progression and regression of coronary artery disease in clinical trials. Circulation 1993;87(suppl II):II66-73.
28. Schwarz F, Preusler W, Reifrat N, Storger H, Baier T, Schlotzer P, et al. Langzeiterfolge nach Koronarangioplastie in Abhängigkeit von der Gefäßgröße. Dtsch Med Wochenschr 1991;116:1857-61.
29. Hirshfeld JW, Schwartz S, Jugo R, MacDonald RG, Goldberg S, Savage MP, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-56.
30. Amann K, Neususs R, Ritz E, Irzyniec T, Wiest G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995;8: 409-17.
31. Topol EJ, Nissen SE. Our preoccupation with coronary luminology - the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-42.
32. Farb A, Virmani R, Atkinson JB, Anderson PG. Long-term histologic patency after percutaneous transluminal coronary angioplasty is predicted by the creation of a greater lumen area. J Am Coll Cardiol 1994;24:1229-35.
33. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis - a special case of atherosclerosis disease progression. Circulation 1992;86(suppl III): III47-52.
34. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-87.
35. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al, for The Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
36. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al, for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:489-95.